The Business Research Company published its HER2 Inhibitors Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global HER2 Inhibitors market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers the HER2 Inhibitors market’s
segments-
1) By Treatment:
Monotherapy, Combination Therapy
2) By
Application: Squamous Cell Carcinoma, Adenocarcinoma, Large Cell Carcinoma,
Breast Cancer, Others.
View Complete Report:
HER2 Inhibitors Global Market Report 2020
is the most comprehensive report available on this market and will help gain a truly global
perspective as it covers 60 geographies. The chapter on the impact of COVID-19
gives valuable insights on supply chain disruptions, logistical challenges, and
other economic implications of the virus on the market. The chapter also covers
markets which have been positively affected by the pandemic.
The global HER2 inhibitors market is
expected to decline from $6.21 billion in 2019 to $6.07 billion in 2020 at a
compound annual growth rate (CAGR) of -2.19%. The decline is mainly due to the
COVID-19 outbreak that has led to restrictive containment measures involving
social distancing, remote working, and the closure of several activities
resulting in operational challenges. The market is then expected to recover and
reach $8.29 billion in 2023 at a CAGR of 10.96%.
Biotechnology companies are focusing on
acquiring or partnering with biopharmaceutical companies to develop and promote
the HER-2 inhibitors market. There have been several partnerships in recent
years which help these companies to increase their HER-2 inhibitors portfolio,
enhance their revenues and share the costs.
Few Points From Table Of Content
1. Executive
Summary
2. Report Structure
3. HER2 Inhibitors Market Characteristics
4. HER2 Inhibitors Market Product Analysis
5. HER2 Inhibitors Market Supply Chain
……
26. Key Mergers And Acquisitions In The HER2 Inhibitors Market
27. HER2
Inhibitors Market Trends And Strategies
28. HER2
Inhibitors Market Future Outlook and Potential Analysis
29. Appendix
Request A Sample Report At:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3396&type=smp
Few Points From List Of Table
Table 1: Global Historic Market Growth, 2015-2019, $
Billion
Table 2: Global
Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global
HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast,
2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4: Global
HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast,
2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 5: Global
HER2 Inhibitors Market, Split By Region, Historic and Forecast, 2015-2019,
2023F, 2025F, 2030F, $ Billion
……..
Table 45: F. Hoffmann-La Roche Ltd. Financial Performance
Table 46: Merck
& Co. Inc. Financial Performance
Table 47:
Novartis AG Financial Performance
Table 48: Pfizer
Inc. Financial Performance
Table 49: Puma
null Inc. Financial Performance
About The Business Research Company:
The Business Research Company is a Business
Intelligence Company which excels in company, market and consumer research. It
has offices in the UK, the US and India and a network of trained researchers in
15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
No comments:
Post a Comment